Lantheus Holdings, Inc. LNTH
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products to assist clinicians in diagnosing and treating heart disease, cancer, and other conditions worldwide. Its portfolio includes DEFINITY, an injectable ultrasound en…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees808
TickerLNTH
Statistics
Market Cap$6.72B
Revenue (TTM)$1.54B
Net Income$233.6M
Net Margin15.2%
EPS$3.41
P/E24.45
P/S4.31
P/B5.50
EV/EBITDA18.12
ROE23.5%
Dividend Yield—
Price$103.22
Data: Twelve Data · Revenue = mcap / P/S